New Website Details Harmful Effects of Salmon Farming Practices from Evidence-Based Research
Salmon.info draws on over 300 peer-reviewed studies and reports to detail the downside of salmon farming.
ST. ANDREWS, NB, June 2, 2025 /CNW/ -- The Atlantic Salmon Federation and the North Atlantic Salmon Fund are proud to announce the launch of salmon.info, a comprehensive evidence-based resource for media professionals, policymakers, and conservationists about the harmful effects of the salmon farming practices that produce one of the world's most consumed fish.
"The salmon farming industry claims to be one of the most sustainable proteins on the planet with minimal environmental impact," said Neville Crabbe, executive director of communications at the Atlantic Salmon Federation. "Our goal for salmon.info is to provide accurate, accessible information on things the salmon farming industry doesn't talk about so that consumers who are eating farmed salmon are informed."
For example, it takes more than one kilogram of wild caught fish to grow one kilogram of farmed Atlantic salmon, and tens of millions of farmed fish die prematurely in sea cages every year - a staggering waste of animal life and resources. There are severe consequences from sea-cage salmon farms on other species, especially wild Atlantic salmon.
Key features of salmon.info include:
Access to over 300 vetted sources that provide in-depth insights into the impacts of open-net pen salmon farming.
An AI assistant that can search the site's database and answer questions from visitors.
Intuitive, user-friendly design with plain-language summaries of all major topics.
Visit www.salmon.info to learn more.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
4 hours ago
- Cision Canada
New Genomics Investments Expand eDNA Monitoring in BC's Remote and Indigenous Communities
VANCOUVER, BC, June 5, 2025 /CNW/ - On World Environment Day, Genome British Columbia (Genome BC) is proud to announce significant new investments that will expand Canada's capacity for environmental DNA or RNA (collectively called 'eDNA') monitoring. These investments highlight British Columbia's leadership in leveraging genomics to address pressing environmental and health challenges, particularly in remote and Indigenous communities. Nature's Fingerprints: eDNA is a New Tool that Reveals What's Living Around Us eDNA is a powerful tool that uses trace genetic material left behind in water, air and soil to detect pathogens, assess ecosystem health and support environmental decision-making. eDNA allows scientists and communities to detect and track species without needing to see them directly, offering a more efficient way to study ecosystems. eDNA can also track health and ecological signals without relying on invasive testing. This technology was widely used during the COVID-19 pandemic to monitor virus levels in wastewater and is now being expanded to keep people safe, protect biodiversity and help with climate resilience. The projects announced today focus on ensuring these tools are not just scientifically robust, but also community-driven and accessible — especially for regions with limited existing monitoring infrastructure. "These investments reflect how genomics is helping us learn directly from the environments we live in — and how that knowledge can be shared in ways that empower communities," said Federica Di Palma, Chief Scientific Officer and Vice President, Research and Innovation at Genome BC. "By supporting eDNA research rooted in partnership with Indigenous and remote communities, BC researchers are helping lead the way toward more inclusive, real-time approaches to health and environmental monitoring." Three Projects Expanding eDNA Use and Data Sharing The ChùNet and iMicroSeq projects are BC-based projects awarded through Genome Canada's eDNA Surveillance program, which includes a $11.3 million investment in 12 projects across the country aimed at building the scientific, technical and community capacity needed to scale eDNA surveillance. The eDNA Explorer Canada project is a separate initiative funded by Genome BC, though all three projects will coordinate their efforts. ChùNet: Enabling a knowledge sharing network — learning from water and the life it carries Led by: Erin Gill (Simon Fraser University) and Math'ieya Alatini (One Yukon Coalition) This project will establish a community-focused network to share data and knowledge about water-based eDNA monitoring in northern, rural, remote and Indigenous communities in BC and the Yukon. Co-led by academic and community partners, ChùNet will create tailored training resources and deploy a demonstration monitoring project while respecting OCAP® principles. The aim is to build a wholistic foundation for integrating environmental and public health surveillance that builds local priorities into decision making. iMicroSeq: Integrated, inclusive resources supporting environmental sequence data Led by: Fiona Brinkman and Emma Griffiths (Simon Fraser University) This project will develop a national data portal and communications platform that brings together researchers, Indigenous communities, public health officials and other in industry to support more coordinated, integrated microbial eDNA monitoring for wastewater and other water data. iMicroSeq will enhance data sharing, respect Indigenous data sovereignty (CARE and OCAP® Principles), and link human, agricultural and environmental health through a One Health lens. The platform will empower both community and industry innovation in economic, water-based pathogen detection and climate resilience. eDNA Explorer Canada: Upscaling eDNA Explorer to Enable Effective Biodiversity Monitoring in Canada Led by: Caren Helbing (University of Victoria) and Rachel Meyer (University of Santa Cruz & Chief Scientific Officer at eDNA Explorer) This project leverages the eDNA Explorer platform developed in California to create eDNA Explorer Canada. This powerful, easy-to-use portal will allow anyone to understand, evaluate and share eDNA data gathered in Canadian ecosystems, focusing on biodiversity monitoring, conservation and restoration. eDNA Explorer Canada is tailored to meet Canadian environmental standards and sovereignty needs, ensuring data is reliable and legally compliant. It aims to turn raw data into actionable insights that drive environmental protection efforts, building on existing relationships with Indigenous and government agencies established through the iTrackDNA project, which in 2021 and 2023 established Canada's national eDNA standards (learn more about those standards here). About Genome British Columbia: Genome BC is a not-for-profit organization that has advanced genomics research and innovation for 25 years, growing a world-class life sciences sector in BC and delivering sustainable benefits for British Columbia, Canada and beyond. Genome BC has attracted over $1 billion in direct co-investment to the province, which has contributed to funding more than 550 genomics research and innovation projects. These initiatives enhance healthcare and address environmental and natural resource challenges, improving the lives of British Columbians. Genome BC also integrates genomics into society by supporting responsible research and innovation and fostering an understanding and appreciation of the life sciences among educators, students and the public.
Cision Canada
6 hours ago
- Cision Canada
FutureCeuticals, Inc. Announces Peer-Reviewed Publication Highlighting Cellular Health and Immune Support Benefits of vitAlign®
MOMENCE, Ill., June 5, 2025 /CNW/ -- New research published in the International Journal of Molecular Sciences shows that vitAlign®, a proprietary and comprehensive healthy aging innovation from FutureCeuticals, delivers significant benefits for restoring cellular health and supporting a healthy immune response. The study highlights vitAlign's effectiveness in regulating cellular function and metabolic imbalances associated with immune stressors—from the seasonal cold and flu to more complex environmental and immune-related challenges. Researchers evaluated the impact of a low, 50 mg dose of vitAlign in medically stable adults aged 40–55 recovering from a moderate course of COVID-19, as defined by CDC guidelines. The study compared vitAlign to a 1000 mg dose of Vitamin C, focusing on key markers and processes that directly impact immune and cellular health. Results showed that vitAlign significantly reduced excessive reactive oxygen species (ROS) production in mitochondria and through the NOX2 and iNOS pathways—key mechanisms that influence immune and cellular function. Additionally, researchers observed increased levels of circulating, bioavailable nitric oxide, suggesting support for endothelial function and cardiovascular health. The authors noted that the increase in nitric oxide is likely attributable to vitAlign's ability to regulate multiple pathways of ROS production. Notably, vitAlign delivered measurable effects within 30 minutes, lasting up to three hours. In contrast, Vitamin C, which was used as a positive control, was administered at twenty times the dose and did not demonstrate comparable broad-spectrum activity. "These findings build on over a decade of published clinical research establishing vitAlign as a significant cellular health innovation, now extended directly to immune function," said J. Randal Wexler, FutureCeuticals' General Counsel and Vice President of R&D. "Previously, we've shown that vitAlign improves cellular energy efficiency and helps restore metabolic balance, both acutely and over time." Wexler added, "These new results, which compare favorably to a well-known antioxidant like Vitamin C, reinforce vitAlign's potential as a multi-faceted phytonutrient formula, providing broad support for healthy aging, cardiovascular health, and immune function. Our partners are excited about what this means for product innovation and their customers looking for daily cellular health support." About FutureCeuticals: FutureCeuticals, Inc. is the developer of vitAlign and a leader in the research, development, and manufacture of plant-based powders and extracts for the functional food, beverage, and dietary supplement markets.
Cision Canada
16 hours ago
- Cision Canada
Statement by Prime Minister Carney on the passing of the Honourable Marc Garneau
OTTAWA, ON, June 4, 2025 /CNW/ - "Today, I join Canadians in mourning the passing of the Honourable Marc Garneau – Canadian naval officer, astronaut, and public servant of exceptional distinction. "Marc made history as the first Canadian in space, inspiring a generation with his courage and intellect. Marc was named a Companion of the Order of Canada – our highest civilian honour. After a decorated career in the Royal Canadian Navy and at the helm of the Canadian Space Agency, Marc brought that same dedication and duty to public life. "As a Member of Parliament, Minister of Transport, and Minister of Foreign Affairs, Marc strived to build a stronger and safer Canada – always guided by deep and abiding purpose. He believed in progress, in science, in integrity, and in humility. Marc brought leadership, focus, and quiet strength to every file – be it strengthening aviation security in conflict zones or negotiating the release of Michael Kovrig and Michael Spavor. "To those who worked alongside him, Marc was a trusted colleague and friend. To Canadians, he was a symbol of national pride and possibility. "I extend my deepest condolences to his family, friends, colleagues, and to all Canadians who looked to him for inspiration. Marc leaves an extraordinary legacy of public service, excellence, and Canadian values."
